UNSPSC 85812128: Introduction of analgesics, hypnotics, sedatives into nose, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of analgesics, hypnotics, sedatives into nose, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E093NZ

UNSPSC 85812128 Introduction of analgesics, hypnotics, sedatives into nose, percutaneous approach is a Commodity code that shows minimal alignment with actual state and local procurement activity. Recent opportunities tagged under this code diverge significantly from its nominal clinical scope—the code describes a specific medical administration route and pharmaceutical category, yet the recent solicitations cluster around telehealth urgent care services, medical director and EMS staffing roles, wellness programs, behavioral health services, and general occupational health services, none of which involve intranasal pharmaceutical delivery.

The issuing bodies posting under this code span state health authorities, county behavioral health and public health divisions, health systems, and municipal agencies across California, Georgia, Nevada, Colorado, Oregon, Kansas, Missouri, Virginia, Texas, Florida, and Illinois. Inland Empire Health Plan (California) posted an RFI for 24/7 virtual urgent care services with a response deadline of October 31, 2026, seeking telehealth-based evaluation and medication prescribing authority—a mismatch with the code's intranasal pharmaceutical specificity. Nevada Health Authority issued an RFP for Program of All Inclusive Care for the Elderly (PACE) operations due December 10, 2026, involving comprehensive multidisciplinary long-term services, and a separate RFP for Rural Value Acceleration Network vendor services due November 30, 2026. The code shows no recent state and local opportunities clearly purchasing or contracting for intranasal analgesic, hypnotic, or sedative administration; the tagging appears to reflect broad healthcare service procurement rather than pharmaceutical delivery method specificity. Procurement professionals should treat this code as showing minimal decision-relevant activity for supply or service lines matching its nominal description.